1ST.AX 1st Group (ASX) up 22.22% intraday 26 Feb 2026: volume spike suggests follow-through
The 1ST.AX stock jumped 22.22% intraday to A$0.011 on 26 Feb 2026 on a volume surge of 2,075,140.00 shares. That volume is roughly 3.06x the average, pushing the microcap toward its year high of A$0.015. Traders should note the move came without a major public corporate release, so momentum and liquidity dynamics are driving the gain. We look at financials, technicals, Meyka AI model forecasts and practical trade points for ASX investors in Australia.
Why 1ST.AX stock is rallying today
The move in 1ST.AX stock is driven by a large intraday volume spike of 2,075,140.00 versus an average of 678,621.00, and a price rise from A$0.009 to A$0.011. With a relative volume of 3.06, short-covering and momentum flows are plausible explanations rather than fresh earnings news. Market participants can check recent regulatory activity for listed companies on Nasdaq filings for broader market rule changes that sometimes affect microcap liquidity source.
Financials and valuation snapshot for 1st Group Limited (1ST.AX)
1st Group (1ST.AX) shows thin revenue per share at A$0.003 and negative earnings: EPS -A$0.01 with a reported P/E -1.10. The company carries a small market capitalisation of A$15,586,889.00 and a tight cash per share of A$0.001. Key ratios point to early-stage or recovering margins: price-to-sales ~3.49, current ratio 0.83, and operating cash flow per share negative. These metrics underline valuation risk for income investors and the stock’s speculative profile in the ASX healthcare services sector.
Technical and trading flow: short-term picture
Price sits at A$0.011, above the 50-day average of A$0.009 and the 200-day average of A$0.008, with a year high at A$0.015 and year low A$0.004. Intraday structure shows a single-price day high and low at A$0.011, reflecting thin order book depth. For traders, the combination of low float (shares outstanding 1,416,989,952.00) and high relative volume increases volatility and slippage risk on entry and exit.
Meyka AI rates and forecast for 1ST.AX stock
Meyka AI rates 1ST.AX with a score out of 100: 65.46 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price around A$0.007 versus the current A$0.011, implying a model-based downside of about -36.36%. These forecasts are model-based projections and not guarantees. For reference on historical price context see Nasdaq historic lookup source.
Risks and catalysts that could change the outlook
Primary risks: microcap liquidity, negative EPS, stretched payables and thin free cash flow. Catalysts that could re-rate the stock include material contract wins for MyHealth1st, growth in GoBookings SaaS revenues, telehealth device rollouts, or a strategic corporate announcement. Given 1st Group’s business mix across healthcare marketplaces and SaaS, execution on higher-margin recurring revenue is the main operational catalyst.
How traders and investors might approach 1ST.AX stock
Short-term traders should use strict risk controls: limit orders, small position sizing, and tight stops because intraday volatility is high. Investors should treat 1ST.AX as speculative and monitor quarterly updates and cash-flow improvement before adding material weight. Suggested near-term levels to watch: support A$0.009, resistance A$0.015, and a conservative short-term price target of A$0.012 if momentum continues.
Final Thoughts
Key takeaways on 1ST.AX stock: intraday strength on 26 Feb 2026 reflects a liquidity-driven momentum move to A$0.011 with a 22.22% rise and volume 2,075,140.00, signaling trader interest. Fundamentals remain stretched: negative EPS -A$0.01, negative operating cash flow per share, and a small market cap A$15,586,889.00. Meyka AI’s forecast model projects A$0.007, implying a model-based downside of -36.36% versus the current price. Short-term upside scenarios rely on sustained volume and clear operational updates; downside risks include low liquidity and continued losses. Traders should prioritise execution discipline. Meyka AI provides this as AI-powered market analysis to help frame risk and reward — forecasts are projections and not guarantees. Monitor corporate announcements, cash flow trends and sector performance before committing size to a portfolio position.
FAQs
What drove the intraday jump in 1ST.AX stock today?
The intraday jump to A$0.011 was driven by a volume surge of 2,075,140.00 shares and momentum flows. There was no major public earnings release; increased trading activity and short-covering likely explain the move.
What is Meyka AI’s short-term forecast for 1ST.AX stock?
Meyka AI’s forecast model projects a yearly level near A$0.007, implying a model-based downside of about -36.36% from A$0.011. Forecasts are model outputs and not guarantees.
Is 1ST.AX stock suitable for long-term investors?
1ST.AX is speculative for long-term investors due to negative EPS, weak cash flow and small market cap. Long-term interest depends on consistent revenue growth, margin expansion, and improved liquidity.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.